Vanberra Signal

dbl-diabetes

Curated by Signal

Provider of monitoring device for diabetes

Overview

diabeloop provides devices to monitor diabetes. The devices are integrated with an app. Its product, DBLG1, is a hybrid closed-loop system for Type 1 diabetes and connects three components: a continuous glucose monitor (CGM), an insulin patch pump, and a locked-down handset that hosts the diabeloop decision-making algorithm. The device is bluetooth enabled, optimizes meal ratio, provides alerts and information. A glucose reading is sent to the handset via bluetooth. Its algorithm analyzes data in real-time and considers the patient’s physiology, history and data entries to determine the dose of insulin.

Key facts

Founded
2018
Headquarters
Grenoble, France

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of EEG-based neuro markers for detecting brain activity

    Life Sciences TechnologyFrance
  • Developer of neuroimaging devices to manage neurological disorders

    Life Sciences TechnologyAmiens, France
  • Provider of solutions for women's health and beauty, with a focus on hormone balance

    Life Sciences TechnologyParis, France

About dbl-diabetes

What does dbl-diabetes do?

diabeloop provides devices to monitor diabetes.

Where is dbl-diabetes headquartered?

dbl-diabetes is headquartered in Grenoble, France.

When was dbl-diabetes founded?

dbl-diabetes was founded in 2018.

Which sector is dbl-diabetes in?

dbl-diabetes operates in Life Sciences Technology.

Who are dbl-diabetes's competitors?

Companies similar to dbl-diabetes include NeuroKyma, Seenel Imaging, and Circles.